Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2003
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321465A2 A process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
06/25/2003EP1320611A2 Heterologous production of polyketides
06/25/2003EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
06/25/2003EP1320529A1 Quinoline derivatives as antibacterials
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1001942B1 Polyhydroxybutylpyrazines, their preparation and medicines containing them
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003EP0673372B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
06/25/2003CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
06/25/2003CN1426408A Pyrimidinyl methyl indole derivatives with antibacterial activity
06/25/2003CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative
06/25/2003CN1426404A Sodium-hydrogen exchangertype 1 inhibitor (NHE-1)
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/24/2003US6583287 Process for the production of paroxetine
06/24/2003US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583162 Chronic dermal ulcers, wound healing
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/24/2003US6583156 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol
06/24/2003US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
06/24/2003US6583149 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane
06/24/2003US6583136 Antifungal ethers
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050109A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/19/2003WO2003049593A2 Prevention of flap necrosis in plastic surgery
06/19/2003WO2003049542A1 Pyrazoles-pyrimidine fungicides
06/19/2003US20030114690 Process for the preparation of aniline compounds
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114671 Corticotropin releasing factor antagonists
06/19/2003US20030114670 Process for preparing substituted pyridines
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114649 Plant fungicide
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114495 Substituted imidazoles as cannabinoid receptor modulators
06/19/2003US20030114493 Antitumor agents
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
06/19/2003US20030114477 Rapamycin 29-Enols
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114445 Bactericides
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114437 Protease inhibitors
06/19/2003US20030114311 Such as 5,6-dichloropyridine-2-carboxylic acid-N-oxide for preemergence application
06/19/2003US20030113665 Optical data medium containing, in the information layer, a dye as a light-absorbing compound
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/19/2003CA2460122A1 Pyrazoles-pyrimidine fungicides
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318985A2 4-amino-quinazolines
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1021414B1 Frangible compounds for pathogen inactivation
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/17/2003US6579901 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
06/17/2003US6579897 For therapy of cancer, arthritis, diabetic retinopathy, restinosis, hepatic cirrhosis, atherosclerosis, angiogenesis, glomerulonephritis, diabetic nephropathy, thrombic microangiopathy syndromes, transplant rejection
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579874 Substituted azoles
06/12/2003WO2003048159A1 Quinoline derivatives
06/12/2003WO2003048157A1 Processes for preparing ¥â-d-ribofuranose derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048152A2 Inflammation modulators
06/12/2003WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
06/12/2003WO2003048130A2 Peroxisome proliferator activated receptor agonists
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048125A1 Aminotetralin derivatives as muscarinic receptor antagonists
06/12/2003WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
1 ... 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 ... 694